EUVIMEDEUVIMED entdecken
Crossref

Prospective Analysis of Factors Influencing Inter-Individual Variation in Trough Plasma Voriconazole Concentrations in Older Patients—Impact of High α1-Acid Glycoprotein Levels

Yukako Yasui, Hiroyuki Yasui, Yoshiki Yamamoto, Toshihiko Ishizaka, Kazuo Hatanaka, Waki Imoto, Wataru Shibata, Koichi Yamada, Hiroshi Kakeya

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b25-00057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Yukako Yasui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sakai City Medical Centre, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai 593-8304, Japan. Hauptthemen laut MEDLINE: Voriconazole, Orosomucoid, Antifungal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Voriconazole (VRCZ), an azole-based, deep-seated antifungal agent, is used as a 1st-line treatment for aspergillosis in Japan. VRCZ exhibits nonlinear pharmacokinetic (PK) behavior with relatively large inter-individual variability in plasma concentration. Additionally, genetic polymorphisms of CYP2C19 have been reported to influence the metabolic variability of VRCZ. The purpose of this study was to search for and identify clinically relevant potential factors influencing the PK and plasma concentration of VRCZ to better inform VRCZ dosing regimens. Thirty patients receiving VRCZ were enrolled. Total (Ct) and unbound (Cu) trough plasma concentrations of VRCZ were determined by the HPLC-UV method. Univariate and multivariate correlation analyses were used to evaluate the relationships between Ct or Ct/dose per body weight (Ct/D) and individual demographic and laboratory characteristics. Since the increasing trend of C-reactive protein (CRP) inversely correlated with the classification of CYP2C19 gene polymorphisms, it was suggested that the inflammation counteracted the trend of Ct according to CYP2C19 gene polymorphisms. Spearman's rank-order correlation analysis showed significant correlations between Ct and dose per body weight, CRP, and α1-acid glycoprotein (α1-AGP). Multivariate linear regression analysis showed that age, dose per body weight, CRP, and α1-AGP were significant explanatory factors for Ct. In particular, elevated α1-AGP levels were found to have significant explanatory value for decreased Ct. Although the present study has critical limitations, such as the patient sample was small in size and being limited to a single medical institution, this finding may explain some of the inter-individual variability in plasma VRCZ concentration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VoriconazoleOrosomucoidAntifungal AgentsHumansMaleAgedCytochrome P-450 CYP2C19FemaleMiddle AgedProspective StudiesAged, 80 and overPolymorphism, GeneticC-Reactive Protein

Stichwörter der Autor:innen

Spearman’s rank-order correlation analysisinflammationmultiple regression analysistherapeutic drug monitoringvoriconazoleα1-acid glycoprotein

Substanzen

VoriconazoleOrosomucoidAntifungal AgentsCytochrome P-450 CYP2C19CYP2C19 protein, humanC-Reactive Protein

Autor:innen und Institutionen

  • Department of Pharmacy, Sakai City Medical Centre, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai 593-8304, Japan.
  • Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
  • Department of Analytical and Bioinorganic Chemistry, Division of Analytical and Physical Chemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.
  • Department of Hematology, Sakai City Medical Centre, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai 593-8304, Japan.
  • Department of Infection Control, Osaka Metropolitan University Hospital, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
  • Research Centre for Infectious Disease Science (RCIDS), Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.

Zitieren

APA

Yasui, Y., Yasui, H., Yamamoto, Y., Ishizaka, T., Hatanaka, K., Imoto, W., Shibata, W., Yamada, K., & Kakeya, H. (2025). Prospective Analysis of Factors Influencing Inter-Individual Variation in Trough Plasma Voriconazole Concentrations in Older Patients—Impact of High α1-Acid Glycoprotein Levels. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00057

Vancouver

Yasui Y, Yasui H, Yamamoto Y, Ishizaka T, Hatanaka K, Imoto W, et al. Prospective Analysis of Factors Influencing Inter-Individual Variation in Trough Plasma Voriconazole Concentrations in Older Patients—Impact of High α1-Acid Glycoprotein Levels. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00057

BibTeX
@article{Yasui2025,
  author = {Yasui, Yukako and Yasui, Hiroyuki and Yamamoto, Yoshiki and Ishizaka, Toshihiko and Hatanaka, Kazuo and Imoto, Waki and Shibata, Wataru and Yamada, Koichi and Kakeya, Hiroshi},
  title = {Prospective Analysis of Factors Influencing Inter-Individual Variation in Trough Plasma Voriconazole Concentrations in Older Patients—Impact of High α1-Acid Glycoprotein Levels},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b25-00057}
}
Kostenlos starten →